Common Stock, Shares, Outstanding of Inmune Bio, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inmune Bio, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Inmune Bio, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 26,585,258, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 26,585,258 +4,412,807 +20% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 26,585,258 +6,878,526 +35% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 22,930,411 +4,979,635 +28% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 22,280,451 +4,329,675 +24% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 22,172,451 +4,226,456 +24% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 19,706,732 +1,760,737 +9.8% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 17,950,776 +4,781 +0.03% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 17,950,776 +4,781 +0.03% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 17,945,995 0 0% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 17,945,995 0 0% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 17,945,995 0 0% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 17,945,995 +102,692 +0.58% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 17,945,995 +102,692 +0.58% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 17,945,995 +2,820,824 +19% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 17,945,995 +3,013,357 +20% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 17,843,303 +4,362,020 +32% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 17,843,303 +4,395,355 +33% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 15,125,171 +4,227,541 +39% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 14,932,638 +4,185,690 +39% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 13,481,283 +2,710,335 +25% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 13,447,948 +2,685,475 +25% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 10,897,630 +135,157 +1.3% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 10,746,948 +1,006,687 +10% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 10,770,948 +2,051,507 +24% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 10,762,473 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 10,762,473 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 9,740,261 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 8,719,441 +400,000 +4.8% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q4 2017 8,319,441 31 Dec 2017 10-K 29 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.